Indian-American Balaji S Srinivasan to be FDA head under Trump

Balaji S Srinivasan of 21 Inc and Counsyl has met with President-elect Donald Trump about the future of the US Food and Drug Administration.

Srinivasan or BSS as he calls himself on his personal blog, is the founder of two early-stage Silicon Valley start-ups: bitcoin payments company 21 Inc and Counsyl- which helps determine Down syndrome in unborn babies.

Balaji S Srinivasan of 21 Inc and Counsyl and Peter Thiel of PayPal.

Srinivasan and another tech investor tied to PayPal co-founder and Trump transition team member Peter Thiel, Mithril Capital Management managing director of investment Jim O’Neill, both met with Trump.

The duo is being considered for a top FDA position, incoming White House press secretary Sean Spicer said in a report.

Balaji S. Srinivasan Photo courtesy: Srinivasan's LinkedIn page

Srinivasan also serves as a partner at VC firm Andreessen Horowitz.

The Indian American executive has been on record in the past criticising the FDA, saying “big bad pharma does exist,” adding that the administration “sets the incentives.”

Srinivasan is a Silicon Valley evangelist with a doctorate in electrical engineering from Stanford University, where he was also teaching data mining, statistics and computational biology.

Author
Garima Kapil
Garima Kapil – Senior Writer

Garima Kapil has around five years of experience in the field of writing and editing. Specialised in writing, performing proof-reading and text editing functions along with content ideation; she has worked with leading e-commerce and as a freelancer. She writes on lifestyle, news, telecom, travel, education, healthcare, immigration, along with other subjects required as a full-time writer and freelancer. 

Comments